FDA Inspection
Medpace IncMedpace Inc – FDA Inspection, Mar 6, 2024
Record Details
This FDA Inspection record concerns Medpace Inc, with an inspection on March 6, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 361b5eb5-bbfa-4117-ae30-7c27ba67b824
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1232744
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Medpace Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Cincinnati District Office | |
| February 13, 2025 | Not classified | Cincinnati District Office | |
| July 11, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 26, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 14, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Medpace Inc
- FDA Inspection 1332930 - 2026-07-31
- FDA Inspection 1263213 - 2025-02-13
- FDA Inspection 1245618 - 2024-07-11
- FDA Inspection 1169068 - 2022-04-26
- FDA Inspection 1145127 - 2021-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.